Zhejiang Hisun Pharmaceutical Co Ltd (600267) — Financial Flexibility Index
Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥541.12 Million (operating CF CN¥438.43 Million minus capex CN¥102.69 Million) represents 0% of total liabilities (CN¥6.56 Billion). Check 600267 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Hisun Pharmaceutical Co Ltd Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Zhejiang Hisun Pharmaceutical Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see Zhejiang Hisun Pharmaceutical Co Ltd (600267) cash flow conversion.
Annual Financial Flexibility Index for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Hisun Pharmaceutical Co Ltd. Explore Zhejiang Hisun Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥2.41 Billion | CN¥2.03 Billion | CN¥6.20 Billion | ▲ +22.0% |
| 2024 | 0.32x | CN¥2.35 Billion | CN¥2.11 Billion | CN¥7.39 Billion | ▲ +67.8% |
| 2023 | 0.19x | CN¥1.76 Billion | CN¥1.52 Billion | CN¥9.26 Billion | ▼ -23.7% |
| 2022 | 0.25x | CN¥2.60 Billion | CN¥2.07 Billion | CN¥10.45 Billion | ▲ +26.7% |
| 2021 | 0.20x | CN¥2.36 Billion | CN¥1.74 Billion | CN¥12.03 Billion | ▲ +8.3% |
| 2020 | 0.18x | CN¥2.28 Billion | CN¥1.59 Billion | CN¥12.60 Billion | ▲ +40.6% |
| 2019 | 0.13x | CN¥1.77 Billion | CN¥698.39 Million | CN¥13.78 Billion | ▼ -38.8% |
| 2018 | 0.21x | CN¥3.05 Billion | CN¥1.45 Billion | CN¥14.48 Billion | ▲ +7.2% |
| 2017 | 0.20x | CN¥2.70 Billion | CN¥1.24 Billion | CN¥13.76 Billion | ▼ -1.8% |
| 2016 | 0.20x | CN¥2.54 Billion | CN¥775.90 Million | CN¥12.72 Billion | ▼ -17.4% |
| 2015 | 0.24x | CN¥2.66 Billion | CN¥736.17 Million | CN¥11.01 Billion | ▼ -19.9% |
| 2014 | 0.30x | CN¥2.73 Billion | CN¥571.04 Million | CN¥9.03 Billion | ▼ -8.6% |
| 2013 | 0.33x | CN¥2.65 Billion | CN¥527.25 Million | CN¥8.01 Billion | ▼ -11.6% |
| 2012 | 0.37x | CN¥2.01 Billion | CN¥375.75 Million | CN¥5.37 Billion | ▼ -25.3% |
| 2011 | 0.50x | CN¥1.82 Billion | CN¥525.31 Million | CN¥3.64 Billion | ▲ +19.3% |
| 2010 | 0.42x | CN¥1.33 Billion | CN¥509.18 Million | CN¥3.18 Billion | ▼ -13.0% |
| 2009 | 0.48x | CN¥1.33 Billion | CN¥472.85 Million | CN¥2.77 Billion | ▲ +42.6% |
| 2008 | 0.34x | CN¥869.53 Million | CN¥221.28 Million | CN¥2.57 Billion | ▼ -27.6% |
| 2007 | 0.47x | CN¥751.07 Million | CN¥437.72 Million | CN¥1.61 Billion | ▲ +70.0% |
| 2006 | 0.27x | CN¥423.70 Million | CN¥108.03 Million | CN¥1.54 Billion | ▼ -1.0% |
| 2005 | 0.28x | CN¥382.28 Million | CN¥113.53 Million | CN¥1.38 Billion | ▼ -56.6% |
| 2004 | 0.64x | CN¥625.46 Million | CN¥312.93 Million | CN¥977.76 Million | ▲ +2.8% |
| 2003 | 0.62x | CN¥542.35 Million | CN¥288.45 Million | CN¥871.96 Million | ▲ +28.2% |
| 2002 | 0.49x | CN¥364.20 Million | CN¥120.82 Million | CN¥750.69 Million | ▼ -25.3% |
| 2001 | 0.65x | CN¥334.46 Million | CN¥69.14 Million | CN¥514.75 Million | ▲ +12.9% |
| 2000 | 0.58x | CN¥258.46 Million | CN¥55.70 Million | CN¥449.01 Million | ▲ +60.0% |
| 1999 | 0.36x | CN¥151.88 Million | CN¥32.64 Million | CN¥422.24 Million | — |